Journal article
Differential Role of “Signal 3” Inflammatory Cytokines in Regulating CD8 T Cell Expansion and Differentiation in vivo
Frontiers in immunology, Vol.2, pp.4-4
2011
DOI: 10.3389/fimmu.2011.00004
PMCID: PMC3342074
PMID: 22566795
Abstract
Following an infection, naïve CD8 T cells are stimulated by dendritic cells (DC) displaying pathogen-derived peptides on MHC class I molecules (signal 1) and costimulatory molecules (signal 2). Additionally, pathogen-induced inflammatory cytokines also act directly on the responding CD8 T cells to regulate their expansion and differentiation. In particular, both type I interferons (IFNs) and IL-12 have been described as critical survival signals (signal 3) for optimal CD8 T cell accumulation during the expansion phase. Furthermore, expansion in numbers of antigen-specific CD8 T cells is coupled with their acquisition of effector functions to combat the infection. However, it still remains unclear whether these same cytokines also regulate the effector/memory differentiation program of the CD8 T cell response
in vivo
. Here, we demonstrate that defective signaling by either type I IFNs or IL-12 to the responding CD8 T cells impairs maximal expansion in response to DC immunization + CpG ODN, but neither of these cytokines is essential to regulate the effector/memory differentiation program. In addition, lack of direct IL-12 signaling to CD8 T cells accelerates the development of central memory phenotype in both primary and secondary antigen-specific memory CD8 T cells.
Details
- Title: Subtitle
- Differential Role of “Signal 3” Inflammatory Cytokines in Regulating CD8 T Cell Expansion and Differentiation in vivo
- Creators
- Nhat-Long L Pham - Interdisciplinary Graduate Program in Immunology, University of IowaVladimir P Badovinac - Department of Pathology, University of IowaJohn T Harty - Interdisciplinary Graduate Program in Immunology, University of Iowa
- Resource Type
- Journal article
- Publication Details
- Frontiers in immunology, Vol.2, pp.4-4
- DOI
- 10.3389/fimmu.2011.00004
- PMID
- 22566795
- PMCID
- PMC3342074
- NLM abbreviation
- Front Immunol
- ISSN
- 1664-3224
- eISSN
- 1664-3224
- Publisher
- Frontiers Research Foundation
- Language
- English
- Date published
- 2011
- Academic Unit
- Microbiology and Immunology; Pathology
- Record Identifier
- 9984047680802771
Metrics
28 Record Views